Bolt Biotherapeutics, Inc.

BOLT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$7-$9-$11-$16
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$1$1
Change in WC-$4-$2-$4-$1
Other Non-Cash$1$0$0$1
Operating Cash Flow-$10-$10-$13-$14
Investing Activities
PP&E Inv.-$0$0$0$0
Net Acquisitions$0$0$1$0
Inv. Purchases-$2-$14-$1-$13
Inv. Sales/Matur.$20$25$15$25
Other Inv. Act.$0$0$0$0
Investing Cash Flow$18$11$15$12
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash$8$1$1-$2
Supplemental Information
Beg. Cash$10$10$9$11
End Cash$19$11$10$9
Free Cash Flow-$10-$10-$13-$14
Bolt Biotherapeutics, Inc. (BOLT) Financial Statements & Key Stats | AlphaPilot